Presentation is loading. Please wait.

Presentation is loading. Please wait.

Pravastatin sodium Pravastatin sodium is an HMG-CoA reductase inhibitor against sterol synthesis with IC50 of 5.6 μM.

Published byBOC Sciences Modified over 6 years ago

Similar presentations

Presentation on theme: "Pravastatin sodium Pravastatin sodium is an HMG-CoA reductase inhibitor against sterol synthesis with IC50 of 5.6 μM."— Presentation transcript:

1 Pravastatin sodium Pravastatin sodium is an HMG-CoA reductase inhibitor against sterol synthesis with IC50 of 5.6 μM.

Download ppt "Pravastatin sodium Pravastatin sodium is an HMG-CoA reductase inhibitor against sterol synthesis with IC50 of 5.6 μM."

Similar presentations

Exercise And Statin – Associated Myopathy Paul D. Thompson, MD Director of Cardiology Henry Low Heart Center Hartford Hospital Hartford, CT.

Exercise And Statin – Associated Myopathy Paul D. Thompson, MD Director of Cardiology Henry Low Heart Center Hartford Hospital Hartford, CT.
Cholesterol Metabolism By Amr S. Moustafa, M.D.; Ph.D.

Cholesterol Metabolism By Amr S. Moustafa, M.D.; Ph.D.
Drugs in dyslipidaemias

Drugs in dyslipidaemias
Cholesterol and Steroid Metabolism Dr. Nikhat Siddiqi1.

Cholesterol and Steroid Metabolism Dr. Nikhat Siddiqi1.
COMPOSITION OF LIPIDS Lipoproteins Apolipoproteins Lipoproteins Apolipoproteins Cholesterol Protein Triglyceride Phospholipid.

COMPOSITION OF LIPIDS Lipoproteins Apolipoproteins Lipoproteins Apolipoproteins Cholesterol Protein Triglyceride Phospholipid.
REGULATION OF ACETYL CoA PROCESSING BIOC 460 DR. TISCHLER LECTURE 37.

REGULATION OF ACETYL CoA PROCESSING BIOC 460 DR. TISCHLER LECTURE 37.
Cholesterol Metabolism

Cholesterol Metabolism
A New Statin Drug: A Brief History of My Career Bonny Ortolano, Ph.D. Genome Pharmaceuticals Cambridge, Massachusetts.

A New Statin Drug: A Brief History of My Career Bonny Ortolano, Ph.D. Genome Pharmaceuticals Cambridge, Massachusetts.
SECONDARY PREVENTIONS Jaimon Stucki MS-1 PSCOM. Blood Draw.

SECONDARY PREVENTIONS Jaimon Stucki MS-1 PSCOM. Blood Draw.
CHOLESTEROL 10/02-03/07 I.LEARNING OBJECTIVES 1) To identify the structure of cholesterol 2) To outline the synthesis of cholesterol 3) To describe the.

CHOLESTEROL 10/02-03/07 I.LEARNING OBJECTIVES 1) To identify the structure of cholesterol 2) To outline the synthesis of cholesterol 3) To describe the.
Cholesterol Metabolism Cardiovascular Block. Overview Introduction Cholesterol structure Cholesteryl esters Cholesterol synthesis Rate limiting step Regulation.

Cholesterol Metabolism Cardiovascular Block. Overview Introduction Cholesterol structure Cholesteryl esters Cholesterol synthesis Rate limiting step Regulation.
Hydroxymethylglutaryl-coenzyme A (HMG-CoA) is the precursor for cholesterol synthesis. HMG-CoA is also an intermediate on the pathway for synthesis of.

Hydroxymethylglutaryl-coenzyme A (HMG-CoA) is the precursor for cholesterol synthesis. HMG-CoA is also an intermediate on the pathway for synthesis of.
Part 5 Antiatheroscleotic drugs. §Plasma lipids § Cholesterol free cholesterol (FC) § cholesterolester (CE) § Triglyceride (TG) § Phospholipid (PL)

Part 5 Antiatheroscleotic drugs. §Plasma lipids § Cholesterol free cholesterol (FC) § cholesterolester (CE) § Triglyceride (TG) § Phospholipid (PL)
Cholesterol metabolism: INTRODUCTION  Cholesterol is a sterol, present in cell membrane, brain and lipoprotein  It is a precursor for all steroids 

Cholesterol metabolism: INTRODUCTION  Cholesterol is a sterol, present in cell membrane, brain and lipoprotein  It is a precursor for all steroids 
Case 15 Andrea De Mesa. Patient history A 44 y/o male, single, undergoes cardiovascular screening on advice of his attending physician. He is a smoker.

Case 15 Andrea De Mesa. Patient history A 44 y/o male, single, undergoes cardiovascular screening on advice of his attending physician. He is a smoker.
MEDC 603 Fall 20071 Principles of Drug Design  Enzyme Inhibition Basics Example: 1) Statins (I) inhibit HMG CoA Reductase (E); S = HMG CoA; P = Mevalonate.

MEDC 603 Fall Principles of Drug Design  Enzyme Inhibition Basics Example: 1) Statins (I) inhibit HMG CoA Reductase (E); S = HMG CoA; P = Mevalonate.
Lipid metabolism Chapter 26 Chem 454: Biochemistry II University of Wisconsin-Eau Claire Chapter 26 Chem 454: Biochemistry II University of Wisconsin-Eau.

Lipid metabolism Chapter 26 Chem 454: Biochemistry II University of Wisconsin-Eau Claire Chapter 26 Chem 454: Biochemistry II University of Wisconsin-Eau.
Lipogenesis. Metabolism of cholesterol.

Lipogenesis. Metabolism of cholesterol.
Cardiovascular Calcium Chanel Blockers 100 200 300 400 500 Ace Inhibitors 100 200 300 400 500 Anticoagulant/ Diuretics 100 200 300 400 500 Lipid Lowering.

Cardiovascular Calcium Chanel Blockers Ace Inhibitors Anticoagulant/ Diuretics Lipid Lowering.
Cholesterol Metabolism.  The chemical and biochemical aspects of cholesterol regarding structure, distribution and biological functions in human body.

Cholesterol Metabolism.  The chemical and biochemical aspects of cholesterol regarding structure, distribution and biological functions in human body.

Similar presentations

Ads by Google